rs2228548

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000493.4(COL10A1):​c.1809G>C​(p.Val603Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0546 in 1,614,142 control chromosomes in the GnomAD database, including 2,694 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 167 hom., cov: 32)
Exomes 𝑓: 0.056 ( 2527 hom. )

Consequence

COL10A1
NM_000493.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.102

Publications

7 publications found
Variant links:
Genes affected
COL10A1 (HGNC:2185): (collagen type X alpha 1 chain) This gene encodes the alpha chain of type X collagen, a short chain collagen expressed by hypertrophic chondrocytes during endochondral ossification. Unlike type VIII collagen, the other short chain collagen, type X collagen is a homotrimer. Mutations in this gene are associated with Schmid type metaphyseal chondrodysplasia (SMCD) and Japanese type spondylometaphyseal dysplasia (SMD). [provided by RefSeq, Jul 2008]
NT5DC1 (HGNC:21556): (5'-nucleotidase domain containing 1) While the exact function of the protein encoded by this gene is not known, it belongs to the 5'(3')-deoxyribonucleotidase family. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 6-116120307-C-G is Benign according to our data. Variant chr6-116120307-C-G is described in ClinVar as Benign. ClinVar VariationId is 256261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.102 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0569 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL10A1NM_000493.4 linkc.1809G>C p.Val603Val synonymous_variant Exon 3 of 3 ENST00000651968.1 NP_000484.2 Q03692A0A650AXN9
NT5DC1NM_152729.3 linkc.529+2362C>G intron_variant Intron 6 of 11 ENST00000319550.9 NP_689942.2 Q5TFE4-1Q9H2R1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL10A1ENST00000651968.1 linkc.1809G>C p.Val603Val synonymous_variant Exon 3 of 3 NM_000493.4 ENSP00000498802.1 Q03692
NT5DC1ENST00000319550.9 linkc.529+2362C>G intron_variant Intron 6 of 11 1 NM_152729.3 ENSP00000326858.3 Q5TFE4-1

Frequencies

GnomAD3 genomes
AF:
0.0443
AC:
6743
AN:
152164
Hom.:
166
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0321
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.0226
Gnomad ASJ
AF:
0.0622
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.0362
Gnomad FIN
AF:
0.0562
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0585
Gnomad OTH
AF:
0.0335
GnomAD2 exomes
AF:
0.0436
AC:
10960
AN:
251476
AF XY:
0.0452
show subpopulations
Gnomad AFR exome
AF:
0.0330
Gnomad AMR exome
AF:
0.0182
Gnomad ASJ exome
AF:
0.0645
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0564
Gnomad NFE exome
AF:
0.0579
Gnomad OTH exome
AF:
0.0438
GnomAD4 exome
AF:
0.0556
AC:
81329
AN:
1461860
Hom.:
2527
Cov.:
37
AF XY:
0.0553
AC XY:
40181
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0307
AC:
1027
AN:
33480
American (AMR)
AF:
0.0192
AC:
859
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0642
AC:
1678
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0365
AC:
3151
AN:
86256
European-Finnish (FIN)
AF:
0.0577
AC:
3082
AN:
53420
Middle Eastern (MID)
AF:
0.0669
AC:
386
AN:
5768
European-Non Finnish (NFE)
AF:
0.0611
AC:
67960
AN:
1111980
Other (OTH)
AF:
0.0527
AC:
3181
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4835
9670
14506
19341
24176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2496
4992
7488
9984
12480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0443
AC:
6748
AN:
152282
Hom.:
167
Cov.:
32
AF XY:
0.0426
AC XY:
3172
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0322
AC:
1336
AN:
41550
American (AMR)
AF:
0.0225
AC:
345
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0622
AC:
216
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.0364
AC:
176
AN:
4832
European-Finnish (FIN)
AF:
0.0562
AC:
596
AN:
10600
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0585
AC:
3977
AN:
68022
Other (OTH)
AF:
0.0331
AC:
70
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
345
690
1036
1381
1726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0558
Hom.:
207
Bravo
AF:
0.0416
Asia WGS
AF:
0.0160
AC:
56
AN:
3478
EpiCase
AF:
0.0551
EpiControl
AF:
0.0573

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Metaphyseal chondrodysplasia, Schmid type Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
2.6
DANN
Benign
0.79
PhyloP100
0.10
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228548; hg19: chr6-116441470; COSMIC: COSV54574975; COSMIC: COSV54574975; API